Skip to main content
OpenTrials

Clinical trial condition

Inflammatory Bowel Diseases

Explore clinical trials studying Inflammatory Bowel Diseases. Study availability and eligibility vary by location and protocol.

1,523 public trials 288 recruiting studies
Refine in advanced search Browse all conditions

Inflammatory Bowel Diseases trial results

Completed

Extension Study of Semapimod 60 mg IV x 3 Days

NCT00741910

Conditions
Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Long Island Clinical Research Associates Great Neck, New York, United States
  • Asher Kornbluth, MD New York, United States
  • Benjamin Franklin University Berlin, Germany
View Trial Details
Completed

Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo

NCT00739986

Conditions
Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
Locations
  • Institute of Healthcare Assessment San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Atlanta Gastroenterology Associates Atlanta, Georgia, United States
  • Advanced Gastroenterology Associates Suwanee, Georgia, United States
View all 28 locations
View Trial Details
Completed

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)

NCT03945019

Conditions
Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
Locations
  • Biopharma Informatic - Houston Houston, Texas, United States
  • Vitebsk Regional Clinical Hospital Vitebsk, Belarus
  • Diagnostic and Consulting Center Aleksandrovska EOOD Sofia, Bulgaria
  • Clinical Hospital Centre Osijek Osijek, Croatia
View all 29 locations
View Trial Details
Completed

Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.

NCT02840721

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
Locations
  • Surgery Center of Aventura Aventura, Florida, United States
  • Venture Ambulatory Surgical Center North Miami Beach, Florida, United States
  • FQL Research, LLC Pembroke Pines, Florida, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View all 28 locations
View Trial Details
Completed

Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)

NCT04706793

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Kojunkai Daido Clinic Nagoya, Aichi-ken, Japan
  • Kojunkai Daido Hospital Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • Toyohashi Municipal Hospital Toyohashi, Aichi-ken, Japan
View all 38 locations
View Trial Details

Related conditions